---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-23-000058"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2023-07-20T23:59:59+00:00"
generated_at: "2026-06-13T05:26:02.324885+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad authorizes new $500M share repurchase program, superseding prior $650M program

## Summary
- Board authorized up to $500M in common stock repurchases; no time limit.
- Prior $650M repurchase program was completed on June 5, 2023.
- Repurchases at management's discretion on open market or privately.
- Acquired shares for employee stock plans, acquisitions, and dilution offset.

## SEC filing metadata
- accession: 0000012208-23-000058
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2023-07-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220823000058/0000012208-23-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220823000058/bio-20230720.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-23-000058
- JSON: https://secwatch.observer/filing/0000012208-23-000058.json
- Plain text: https://secwatch.observer/filing/0000012208-23-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.